(Q38154959)

29 August 2017

title

Tumor-associated edema in brain cancer patients: pathogenesis and management (English)

1 reference

29 August 2017

0 references

1 reference

4

Michael Weller

1 reference

29 August 2017

2

0 references

author name string

Patrick Roth

series ordinal

1

1 reference

29 August 2017

Michaela Tonder

series ordinal

3

1 reference

29 August 2017

language of work or name

1 reference

23 October 2013

1 reference

Expert Review of Anticancer Therapy

29 August 2017

published in

1 reference

29 August 2017

volume

13

1 reference

29 August 2017

issue

11

1 reference

29 August 2017

page(s)

1319-1325

1 reference

Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edema

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Patterns in neurosurgical adverse events: intracranial neoplasm surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Perioperative steroids for peritumoral intracranial edema: a review of mechanisms, efficacy, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Risk factors for posttreatment edema in patients treated with stereotactic radiosurgery for meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Electron microscopy of the blood-brain barrier in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Expression and distribution of vascular endothelial growth factor protein in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic brain edema and tumor-associated cysts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Correlation between dynamic contrast-enhanced perfusion MRI relative cerebral blood volume and vascular endothelial growth factor expression in meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Angiogenesis in brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Increased leukotriene C4 and vasogenic edema surrounding brain tumors in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Cyclooxygenase-2 expression in astrocytes and microglia in human oligodendroglioma and astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

The eicosanoid cascade: possible role in gliomas and meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Expression of cyclooxygenase-2 and its correlation with vasogenic brain edema in human intracranial meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

The role of eNOS in vascular permeability in ENU-induced gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Ultrastructure of capillary walls in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

A quantitative study of blood-brain barrier permeability ultrastructure in a new rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Occludin expression in microvessels of neoplastic and non-neoplastic human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Aquaporins in brain: distribution, physiology, and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Increased aquaporin 1 water channel expression in human brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Aquaporin-4 expression is increased in oedematous human brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Expression pattern of the water channel aquaporin-4 in human gliomas is associated with blood-brain barrier disturbance but not with patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

AQP-4 in peritumoral edematous tissue is correlated with the degree of glioma and with expression of VEGF and HIF-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Expression of aquaporin 5 and the AQP5 polymorphism A(-1364)C in association with peritumoral brain edema in meningioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Cortisone and ACTH as an adjunct to the surgery of craniopharyngiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Steroids in neurooncology: actions, indications, side-effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Corticosteroid-use in primary and secondary brain tumour patients: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Corticotropin-releasing factor: an inhibitor of vascular leakage in rat skeletal muscle and brain cortex after injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Corticorelin acetate injections for the treatment of peritumoral brain edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

A phase I trial of human corticotropin-releasing factor (hCRF) in patients with peritumoral brain edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Comparison of corticotropin-releasing factor, dexamethasone, and temozolomide: treatment efficacy and toxicity in U87 and C6 intracranial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Steroid-sparing effect of corticorelin acetate in peritumoral cerebral edema is associated with improvement in steroid-induced myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Boswellic acids in the palliative therapy of children with progressive or relapsed brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Hypertonic saline ameliorates cerebral edema associated with experimental brain tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Steroid-sparing effects of angiotensin-II inhibitors in glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

Inhibition of SUR1 decreases the vascular permeability of cerebral metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.852473

10.1586/14737140.2013.852473

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference